跳至主要内容
临床试验/NCT01080040
NCT01080040已完成不适用

Observational Study to Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Patients With Multiple Sclerosis in Argentina

Merck KGaA, Darmstadt, Germany1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2008年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Assess the prevalence of spasticity in subjects with RRMS

研究概览

简要总结

This study is observational, non-controlled, multicentric and prospective, without experimental intervention or control. As part of the usual management of the subjects, scales will be used for the assessment of the spasticity and the quality of life (QoL).

The purpose of this observational study is to assess the incidence of spasticity in a group of subjects with Relapsing Remitting Multiple Sclerosis (RRMS) in Argentina and the way it affects the QoL of these subjects.

详细描述

One of most frequently observed symptoms in subjects with MS is spasticity. Spasticity is defined as an abnormal velocity-dependent increase in muscle tonic stretch reflexes due to an amplified reactivity of motor segments to sensory input. It is part of one of the components of the superior motoneurone syndrome and it may cause muscle rigidity and disability.

The spasticity, which could be measured in electrophysiological, biomechanical and clinical terms, has a significant prevalence. It is a frequent cause for consultation among subjects with MS and, consequently, has a significant impact on the QoL. Men and those subjects with MS of longer duration are the most affected by spasticity.

The aim of this study is to assess the impact that spasticity has on the QoL of subjects with MS.

The total duration of the study is 24 months. The recruiting period will be 12 months. Once the recruiting time is over, the collection of data will continue during the full 24 months period that was planned.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects aged from 21 60 years of age
  • •Subjects with established diagnosis of RRMS according to the revised McDonald criteria - 2005
  • •Subjects with a diagnosis of RRMS for more than one year
  • •The subject who have signed the Informed Consent

排除标准

  • •Subjects with other causes of spasticity
  • •Subjects with other clinical forms of MS (different from relapsing-remitting)

结局指标

主要结局

Assess the prevalence of spasticity in subjects with RRMS

时间窗: Initial visit (Day 0) to 24 months

Ashworth Scale (AS) (Spasticity) Expanded Disability status scale (EDSS) SF 36

次要结局

  • Evaluation of the impact of spasticity on the quality of life of subjects with RRMS(Initial visit (Day 0) to 24 months)
  • Evaluation of the changes in spasticity after 24 months(Initial visit (Day 0) to 24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验